Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olmesartan Mega study to determine the relationship between Cardiovascular Endpoints and Blood pressure Goal Achievement
jRCT1080220002
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of olmesartan in essential hypertension, sponsored by Daiichi Sankyo Co., Ltd. Primary endpoints: Cardiovascular endpoints and Blood pressure goal achievement.
02
Drugs
olmesartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on jRCT1080220002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080220002.